心血管计算机断层扫描 (PREDICT-CT) 的临床效用和结果预测 (PREDICT-CT)
In this study the investigators retrospectively and prospectively collect information from enrolled subjects undergoing CCTA and evaluate the association of cardiac and non-cardiac imaging with laboratory markers and clinical data including outcome.
研究概览
详细说明
In this study the investigators retrospectively and prospectively collect information from enrolled subjects through a period of a total of 10 years to evaluate multidimensional associations between phenotypic manifestations of cardiovascular disease via CCTA and cardiac and non-cardiac imaging, serum biomarkers, demographic and clinical information, clinical presentation (cross-sectional), therapy changes (time-varying) and their ability to predict mortality and MACE (major adverse cardiac event ) (longitudinal) in patients clinically indicated for CCTA.
The aim is to establish a comprehensive cross-sectional, time-varying and longitudinal data collection for individuals undergoing clinically-indicated CCTA to date in order to apply novel multiparametric approaches to determine cardiovascular significance to clinically-important patient-centered events. For data collection this registry will follow a standard CRF (case report form) structure, so to enable the merging of this data-set with other international registries, which might contribute in overcoming some gaps of knowledge from previous CCTA studies.
研究类型
注册 (估计的)
联系人和位置
学习联系方式
- 姓名:Christoph Gräni, MD, PHD
- 电话号码:+41 31 632 4508
- 邮箱:christoph.graeni@insel.ch
学习地点
-
-
-
Bern、瑞士、3010
- 招聘中
- Department of Cardiology, University Hospital Bern, Inselspital, Bern
-
接触:
- Christoph Gräni, Prof
- 电话号码:+41316324508
- 邮箱:christoph.graeni@insel.ch
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
The registry foreseen a prospective cohort composed by patients undergoing clinically indicated CCTA and by a retrospective population of patients that have undergone CCTA 1st June 2017 to 31st December 2020. The principal investigator confirms that no patient's personal health data will be collected if a written or documented oral refusal exist.
描述
Inclusion Criteria:
- Adult individual >18 years
- Undergoing clinically indicated CCTA
- Signed informed consent or waiver
Exclusion Criteria:
- None
学习计划
研究是如何设计的?
设计细节
- 观测模型:COHORT
- 时间观点:PROSPECTIVE
队列和干预
团体/队列 |
|---|
|
Patients undergoing clinically indicated CCTA
Patients undergoing clinically indicated CCTA |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
All-cause death.
大体时间:10 years
|
The primary endpoint is the time to first occurrence of death from all-causes. |
10 years
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Major adverse cardiovascular events (MACE)
大体时间:10 years
|
The secondary composite endpoint is major adverse cardiac events (MACE), which is defined by the occurrence of any of the following events:
|
10 years
|
|
Other outcome
大体时间:10 years
|
Occurrence of any of the following events:
|
10 years
|
合作者和调查者
调查人员
- 首席研究员:Christoph Gräni, MD, PhD、Department of Cardiology, University Hospital Bern,
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.